Toggle Main Menu Toggle Search

Open Access padlockePrints

Browsing publications by Professor Annemieke Aartsma-Rus

Newcastle AuthorsTitleYearFull text
Dr Nathalie Doorenweerd
Professor Annemieke Aartsma-Rus
Longitudinal follow-up of verbal span and processing speed in Duchenne muscular dystrophy2020
Dr John Bourke
Professor Michela Guglieri
Professor Annemieke Aartsma-Rus
Dr Guy MacGowan
238th ENMC International Workshop: Updating management recommendations of cardiac dystrophinopathyHoofddorp, The Netherlands, 30 November - 2 December 20182019
Dr Nathalie Doorenweerd
Professor Annemieke Aartsma-Rus
Erratum: Author Correction: Timing and localization of human dystrophin isoform expression provide insights into the cognitive phenotype of Duchenne muscular dystrophy (Scientific reports (2017) 7 1 (12575))2018
Professor Hanns Lochmuller
Dr Dorota Badowska
Rachel Thompson
Professor Annemieke Aartsma-Rus
Libby Johnston
RD-Connect, NeurOmics and EURenOmics: collaborative European initiative for rare diseases2018
Dr Mojgan Reza
Professor Vishna Devi V Nadarajah
Professor Hanns Lochmuller
Professor Annemieke Aartsma-Rus
Evaluation of serum MMP-9 as predictive biomarker for antisense therapy in Duchenne2017
Dr Ingrid Verhaart
Agata Robertson
Dr Ian Wilson
Professor Annemieke Aartsma-Rus
Dr Shona Cameron
et al.		Prevalence, incidence and carrier frequency of 5q-linked spinal muscular atrophy - A literature review2017
Becca Leary
Dr Anne Oyewole
Emerita Professor Katherine Bushby
Professor Annemieke Aartsma-Rus
Translational Research in Europe for theAssessment and Treatment for NeuromuscularDisorders (TREAT-NMD)2017
Professor Annemieke Aartsma-Rus
Professor Volker Straub
Professor Hanns Lochmuller
Association Study of Exon Variants in the NF-κB and TGFβ Pathways Identifies CD40 as a Modifier of Duchenne Muscular Dystrophy2016
Dr Mattia Calissano
Professor Hanns Lochmuller
Professor Annemieke Aartsma-Rus
Comparative mass spectrometric and immunoassay-based proteome analysis in serum of Duchenne muscular dystrophy patients2016
Professor Volker Straub
Emerita Professor Katherine Bushby
Dr Monica Ensini
Professor Annemieke Aartsma-Rus
Stakeholder cooperation to overcome challenges in orphan medicine development: the example of Duchenne muscular dystrophy2016
Dr Stephen Lynn
Professor Annemieke Aartsma-Rus
Emerita Professor Katherine Bushby
Dr Anna Mayhew
Professor Volker Straub
Measuring clinical effectiveness of medicinal products for the treatment of Duchenne muscular dystrophy2015
Dr Catherine Bladen
Professor Jordi Diaz Manera
Professor Volker Straub
Emerita Professor Katherine Bushby
Professor Annemieke Aartsma-Rus
et al.		The TREAT-NMD DMD Global Database: Analysis of More than 7,000 Duchenne Muscular Dystrophy Mutations2015
Dr Amina Chaouch
Emerita Professor Katherine Bushby
Professor Volker Straub
Professor Hanns Lochmuller
Professor Annemieke Aartsma-Rus
Validation of genetic modifiers for Duchenne muscular dystrophy: a multicentre study assessing SPP1 and LTBP4 variants2015
Dr Ingrid Verhaart
Professor Annemieke Aartsma-Rus
A 3-base pair deletion, c.9711_9713del, in DMD results in intellectual disability without muscular dystrophy2014
Dr Mojgan Reza
Professor Vishna Devi V Nadarajah
Dr Mattia Calissano
Professor Hanns Lochmuller
Professor Annemieke Aartsma-Rus
MMP-9 serum levels increase over time in Duchenne muscular dystrophy patients and decrease upon treatment with drisapersen2014
12